T1	Participants 234 282	patients after abdominoperineal resection (APR).
T2	Participants 325 451	patients with rectal cancer, ulcerative colitis or rectal gastrointestinal stromal tumor, who underwent APR or proctocolectomy
T3	Participants 1010 1052	74 patients were enrolled in present study
